Molecular mechanisms of corona drug candidate Molnupiravir unraveled
The Pharma Data
AUGUST 16, 2021
The antiviral agent incorporates RNA-like building blocks into the RNA genome of the virus. If this genetic material is further replicated, defective RNA copies are produced and the pathogen can no longer spread. ” Mutations in the genome stop the virus.
Let's personalize your content